BioCryst Reports Second Quarter 2026 Financial Results

Go back to BioCryst Reports Second Quarter 2026 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 9.38 +0.08 (0.86%)
Previous Close $9.30    52 Week High $10.98 
Open $9.50    52 Week Low $1.63 
Day High $9.67    P/E N/A 
Day Low $9.23    EPS $-0.68 
Volume 4,383,547